Innovarx Global Health, LLC
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Innovarx Global Health, LLC - overview
Established
2014
Location
-, -, Gambia
Primary Industry
Software
About
Innovarx Global Health specializes in providing healthcare services and products, focused on enhancing medical care access across Africa through innovative solutions, including digital health platforms and community pharmacy services. Innovarx Global Health, LLC was founded in 2014 in The Gambia and operates as an independent entity. The company is led by CEO Ismail Badjie. They achieved their first significant milestone through a single deal completed in June 2021.
The firm has not undergone any notable pivots or changes in strategy since its inception. InnovaRx Global Health delivers a comprehensive suite of healthcare services and products aimed at enhancing access to quality medical care across various regions in Africa. Its core offerings include the WOW (Wellness On Wheels) Health Services, which provide extensive clinical consultations with a diverse team of healthcare professionals, including physicians, nutritionists, and mental health therapists. The company operates IGH Community Pharmacy, a fully digitized pharmacy that prioritizes patient safety through electronic prescription processing and personalized medication labeling.
Additionally, InnovaRx markets the Agastha EMR, a cloud-based electronic medical records management platform that serves healthcare facilities in The Gambia, Ghana, and Nigeria. The services cater to a diverse client base, ranging from individual patients seeking preventive care to healthcare providers utilizing the EMR system for efficient patient management. InnovaRx Global Health generates revenue through a multi-faceted business model that includes direct-to-consumer offerings and partnerships with healthcare providers. The company utilizes subscription-based plans, such as the Yellow Zone and Green Zone healthcare packages, which provide various benefits including consultations, prescription refills, and preventive screenings at fixed annual prices of USD 165 and USD 250, respectively.
Additionally, the organization capitalizes on its community pharmacy service by facilitating transactions involving retail sales of prescription and over-the-counter medications, further bolstering its financial performance. This revenue structure is designed to promote consistent patient engagement while ensuring accessibility to essential healthcare services across the regions it serves. InnovaRx Global Health has plans to introduce new healthcare products, although specific details on upcoming launches have not been disclosed. The company aims to expand its services into additional markets within Africa, targeting regions such as Nigeria and Ghana by the end of 2023.
The recent funding raised in June 2021 will be utilized to support these expansion initiatives and enhance their service offerings.
Current Investors
StartUp Health
Primary Industry
Software
Sub Industries
Medical Software, Systems Management Software
Website
www.innovarxglobal.com
Verticals
E-commerce, HealthTech
Company Stage
Early Stage
Total Amount Raised
Subscriber access only

Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.